Initial Treatment of Pediatric Graves’ Disease with Methimazole: A Retrospective Follow-up Study

Antithyroid drugs are widely used in the therapy of Graves’ disease (GD), and methimazole (MMI) is preferred for treatment of pediatric GD. The recommended initial dosage of MMI is 0.5–1.0 mg/kg/d for pediatric GD, although there are few studies on the optimal MMI dosage for initial treatment in chi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Matsushita, Rie, Nakagawa, Yuichi, Nagata, Eiko, Satake, Eiichiro, Sano, Shinichiro, Yamaguchi, Rie, Fujisawa, Yasuko, Masui, Ayako, Nakanishi, Toshiki, Endo, Akira, Kagawa, Jiro, Ohzeki, Takehiko
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society for Pediatric Endocrinology 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687628/
https://ncbi.nlm.nih.gov/pubmed/23926385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.19.101
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados